Age: 16.0
Sex: M
Vaccine: COVID19, HEPA, MEN, MENB
Symptoms: Pain in extremity, Underdose, Wrong product administered
Clinical narrative: Patient did not have any other side effects besides expected soreness in arms; Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024); Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024); This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024)), UNDERDOSE (Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024)) and PAIN IN EXTREMITY (Patient did not have any other side effects besides expected soreness in arms) in a 16-year-old male patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5558B) for COVID-19 prophylaxis.    Co-suspect products included non-company products MENINGOCOCCAL VACCINE A/C/Y/W CONJ (TET TOX) (MENQUADFI) for an unknown indication, MENINGOCOCCAL VACCINE B RFHBP/NADA/NHBA OMV (BEXSERO) for an unknown indication and HEPATITIS A VACCINE (HEPATITIS A) for an unknown indication.    No Medical History information was reported.   On 03-May-2024, the patient received first dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .25 milliliter, dose of MENINGOCOCCAL VACCINE A/C/Y/W CONJ (TET TOX) (MENQUADFI) (Intramuscular use) 1 dosage form, dose of MENINGOCOCCAL VACCINE B RFHBP/NADA/NHBA OMV (BEXSERO) (Intramuscular use) 1 dosage form and dose of HEPATITIS A VACCINE (HEPATITIS A) (Intramuscular use) 1 dosage form. On 03-May-2024, the patient experienced WRONG PRODUCT ADMINISTERED (Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024)) and UNDERDOSE (Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024)). On an unknown date, the patient experienced PAIN IN EXTREMITY (Patient did not have any other side effects besides expected soreness in arms). At the time of the report, WRONG PRODUCT ADMINISTERED (Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024)), UNDERDOSE (Got the Moderna COVID vaccine for 6 months and up, so instead of getting the 0.5mls he received the 0.25mls of the Moderna COVID-19 (2023-2024)) and PAIN IN EXTREMITY (Patient did not have any other side effects besides expected soreness in arms) outcome was unknown.        For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments.   It was reported that patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication was not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-May-2024: Follow-up received and added reporter details, added patient details, updated ROA and anatomical location of the suspect and for co-suspects, updated co-suspect name, added new event of pain in extremity, updated narrative.